Ophthalmology

Jacksonville, Florida | April 10, 2026 Johnson & Johnson has presented new clinical data for its TECNIS PureSee™ intraocular...

ENCINITAS, California, United States, April 7, 2026 Kiora Pharmaceuticals, Inc. announced the successful completion of a private placement financing...

Thousand Oaks, California, USA, April 6, 2026 Phase 3 Success Expands TEPEZZA Treatment Options In a major advancement for...

TARRYTOWN, N.Y., April 2, 2026 Regeneron Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...

RAHWAY, N.J., April 2, 2026 Merck (MSD) has announced the initiation of a pivotal Phase 2b/3 clinical trial (MALBEC)...

MALVERN, Pa., USA — April 1, 2026 Ocugen, Inc. has announced the early completion of dosing in its Phase...

BLOOMINGTON, Minn., USA, March 31, 2026 i-Lumen Scientific has received FDA Investigational Device Exemption (IDE) approval to initiate U.S....

MALVERN, Pennsylvania, USA | March 24, 2026 In a major breakthrough for retinal disease treatment, Ocugen, Inc. has announced...

Del Mar, California, USA | March 23, 2026 Sydnexis, Inc. has announced new Phase 3 clinical data from its...

PALO ALTO, Calif., Feb. 4, 2026 —Kodiak Sciences Inc. announced that final end-of-study Phase 1b APEX clinical results evaluating...